tiprankstipranks
Ascletis Pharma, Inc. (HK:1672)
HKEX:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Stock News & Sentiment

0 Followers
Ascletis Pharma Announces Share Buyback Plan
PremiumCompany Announcements
Ascletis Pharma Announces Share Buyback Plan
17h ago
Ascletis Pharma, Inc. (HK:1672) has released an update. Ascletis Pharma Inc. has announced its plan to buy back shares worth up to HK$200 million under the Repurchase Mandate, aiming to ...Read more
Ascletis Pharma’s Drug Shows Positive Trial Results
PremiumCompany Announcements
Ascletis Pharma’s Drug Shows Positive Trial Results
22d ago
Ascletis Pharma Shareholders Show Solid Support
PremiumCompany Announcements
Ascletis Pharma Shareholders Show Solid Support
1M ago

1672 News on the Web

TipRanks News
Bullish

News Score - Last 7 Days

Neutral
HK:1672
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1672’s Media Buzz Sentiment?
1 articles about HK:1672 were published this week. In an average week, 1 articles are published.
    What is HK:1672’s weekly average amount of articles?
    In an average week, 1 articles about HK:1672 are published.
      What is HK:1672’s News Sentiment?
      100% of articles about HK:1672 were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        WBAWalgreens Boots Alliance
        DMACDiamedica Therapeutics
        CALCCalciMedica
        OGNOrganon
        ELTPElite Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis